BOSTON--(BUSINESS WIRE)--Today, Ipsen (Euronext: IPN; ADR: IPSEY), a global biopharmaceutical group, announced it will establish its North American headquarters in Cambridge, Massachusetts. The ...

The first phase of a three-part expansion at Trelleborg AB's BioPharma Center of Excellence in Northborough, Mass., is set to be operational by 2023. The 25,000-square-foot expansion for ...

Oncology was the top therapy area for M&A deals in Q1 2024, with a total deal value of $29 billion. (Image Credits: Pixabay) GlobalData, data and analytics company, on Tuesday announced that the ...

Biopharmaceutical Process and Quality Consortium (BPQC) is an interdisciplinary and multi-university research collaboration based on Massachusetts BioManufacturing Center at UMass Lowell. With a close ...

Global Biopharmaceutical Company, Ipsen Announces New Headquarters for North America will be located in Cambridge, Massachusetts -- Ipsen commits to creating global hub in North America, expects to ...